The first Brazilian vaccine against avian flu will enter the phase of clinical tests in humans after authorization from the National Health Surveillance Agency (Anvisa). The immunological is being developed by the Butantan Institute in São Paulo.
The institute will recruit 700 volunteers in the states of Pernambuco, Minas Gerais and São Paulo. Participants will be divided into two age groups, between 18 and 59 years and over 60 years.
Those interested in participating in the testing phase should meet the eligibility criteria and be over 18 years old. One form was made available for the registration of participants In this link.
Pregnant women, women trying to get pregnant or breastfeeding, people with untt controlled clinical condition, allergic to egg and people or in the process of immunosuppressive therapy, cannot participate.
The initiative will evaluate the safety and immunological efficacy of the new vaccine. The testing phase will be led by researchers from Fiocruz Pernambuco and the Plastic Clinical Research Center, Rafael Dhalia and Carlos Brito.
The test vaccine presents itself as a possible tool for the creation of effective antibodies against avian flu, acting as a preventive pillar to avoid a new pandemic crisis
Rafael Dhalia do Plátano Clinical Research Center
Participants will receive two doses of vaccine or placebo. The interval between doses is 21 days. Only 1 among 7 volunteers will receive the placebo.
The clinical study will be conducted at the Plastanian Center for Clinical Research lasting seven months. At this time, participants will be accompanied by visits and examinations to evaluate the immunological safety and effectiveness of the immunizer.
An initial screening will also be made with biochemical, hematological and serological examinations that will be performed at the Real Portuguese Hospital. Cell immunity analysis of the vaccine will be conducted in Fiocruz Pernambuco.
This content was originally published in the first Brazilian vaccine against Avian flu will enter testing on the CNN Brazil website.
Source: CNN Brasil
I’m James Harper, a highly experienced and accomplished news writer for World Stock Market. I have been writing in the Politics section of the website for over five years, providing readers with up-to-date and insightful information about current events in politics. My work is widely read and respected by many industry professionals as well as laymen.
